Ticker Details
Cerus Corporation Cerus Corp is a biomedical products company. It is engaged in developing and commercializing the INTERCEPT Blood System to enhance blood safety.
IPO Date:	January 31, 1997
Sector:	Healthcare
Industry:	Health Care Equipment and Supplies
Market Cap:	$501.8M
Activated in VL:	True

Average Daily Range
Avg Daily Range:	$0.13 | 3.13%
Avg Daily Range (30 D):	$0.06 | 2.40%
Avg Daily Range (90 D):	$0.09 | 3.25%

Institutional Daily Volume
Avg Daily Volume:	.8M
Avg Daily Volume (30 D):	2.05M
Avg Daily Volume (90 D):	2.1M

Trade Size
Avg Trade Size (Sh.):	180
Avg Trade Size (Sh.) (30 D):	187
Avg Trade Size (Sh.) (90 D):	184

Institutional Trades
Total Institutional Trades:	1,041
Avg Institutional Trade:	$1.25M
Avg Institutional Trade (30 D):	$.79M
Avg Institutional Trade (90 D):	$.97M
Avg Institutional Trade Volume:	.26M
Avg Institutional Trades (Per Day):	1

Market Closing Trades
Avg Closing Trade:	$1.22M
Avg Closing Trade (30 D):	$.79M
Avg Closing Trade (90 D):	$.98M
Avg Closing Volume:	241.14K

News

Jul 17, 2024 @ 12:21 PM ASML Reports Q2 Results, Joins Spirit Airlines And... Source: Avi Kapoor

Jul 17, 2024 @ 10:03 AM Why Bloom Energy Group Shares Are Trading Higher B... Source: Avi Kapoor

Apr 8, 2024 @ 12:24 PM Perion Network Cuts Sales Outlook, Joins Range Res... Source: Avi Kapoor

Mar 21, 2024 @ 3:40 AM Cathie Wood's Ark Invest Sells Another Tranche Of ... Source: Benzinga Neuro

Mar 14, 2024 @ 3:41 AM Cathie Wood's Ark Invest Sells Coinbase Shares As ... Source: Benzinga Neuro

Financials
	TTM	Q2 2026	Q1 2026
Basic EPS	$-.03	$-.01	$-.01
Diluted EPS	$-.03	$-.01	$-.01
Revenue	$277.2M	$57.44M	$53.66M
Gross Profit
Net Income / Loss	$-6.83M	$-2.98M	$-1.65M
Operating Income / Loss	$-1.62M	$-1.86M	$-.35M
Cost of Revenue
Net Cash Flow	$1.48M
PE Ratio